| 1 |
El-Zahaby SA, Elnaggar YSR, Abdallah OY. Reviewing two decades of nanomedicine implementations in targeted treatment and diagnosis of pancreatic cancer: An emphasis on state of art. J Control Release 2019;293:21-35. [PMID: 30445002 DOI: 10.1016/j.jconrel.2018.11.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 2 |
El-zahaby SA, Elnaggar YS, Abdallah OY. Reviewing two decades of nanomedicine implementations in targeted treatment and diagnosis of pancreatic cancer: An emphasis on state of art. Journal of Controlled Release 2019;293:21-35. [DOI: 10.1016/j.jconrel.2018.11.013] [Reference Citation Analysis]
|
| 3 |
Lamb YN, Scott LJ. Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma. Drugs 2017;77:785-92. [PMID: 28401446 DOI: 10.1007/s40265-017-0741-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 4 |
Mostoufi H, Yousefi G, Tamaddon A, Firuzi O. Reversing multi-drug tumor resistance to Paclitaxel by well-defined pH-sensitive amphiphilic polypeptide block copolymers via induction of lysosomal membrane permeabilization. Colloids and Surfaces B: Biointerfaces 2019;174:17-27. [DOI: 10.1016/j.colsurfb.2018.10.072] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 5 |
Li Y, Cui XL, Chen QS, Yu J, Zhang H, Gao J, Sun DX, Zhang GQ. Cationic liposomes induce cytotoxicity in HepG2 via regulation of lipid metabolism based on whole-transcriptome sequencing analysis. BMC Pharmacol Toxicol 2018;19:43. [PMID: 29996945 DOI: 10.1186/s40360-018-0230-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Greene MK, Johnston MC, Scott CJ. Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance. Cancers (Basel) 2021;13:6175. [PMID: 34944794 DOI: 10.3390/cancers13246175] [Reference Citation Analysis]
|
| 7 |
Coccè V, Farronato D, Brini AT, Masia C, Giannì AB, Piovani G, Sisto F, Alessandri G, Angiero F, Pessina A. Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma. Sci Rep 2017;7:9376. [PMID: 28839168 DOI: 10.1038/s41598-017-09175-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 8 |
Petrella F, Coccè V, Masia C, Milani M, Salè EO, Alessandri G, Parati E, Sisto F, Pentimalli F, Brini AT, Pessina A, Spaggiari L. Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells. Biomed Pharmacother 2017;87:755-8. [PMID: 28153512 DOI: 10.1016/j.biopha.2017.01.118] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 9 |
Dilly S, Garnier M, Solé M, Bailly R, Taib N, Bestel I. In Silico Identification of a Key Residue for Substrate Recognition of the Riboflavin Membrane Transporter RFVT3. J Chem Inf Model 2020;60:1368-75. [DOI: 10.1021/acs.jcim.9b01020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Petrella F, Rimoldi I, Facchetti G, Spaggiari L. Novel platinum agents and mesenchymal stromal cells for thoracic malignancies: state of the art and future perspectives. Expert Opin Ther Pat 2018;28:813-21. [PMID: 30246568 DOI: 10.1080/13543776.2018.1528234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
